Baidu
map

感染性疾病检测中的四大名捕

2019-10-29 唐晶 检验医学网

今天我们来聊聊目前临床遇到的最常见的感染性疾病,在其实验室辅助检测中也有对应的四大名捕。

四大名捕是温瑞安创作的武侠小说中的四大高手,其成员分别是无情(大师兄 四大名捕之首)、铁手(二师兄)、追命(三师兄)、冷血(四师弟), 四人都是武林中的数一数二的好手,各有其过人之能,人人俱有独特绝技。今天我们来聊聊目前临床遇到的最常见的感染性疾病,在其实验室辅助检测中也有对应的四大名捕。

这四大名捕分别是:

白细胞计数(WBC)

C反应蛋白(CRP)

血清淀粉样蛋白A(SAA)

降钙素原(PCT)

WBC(大师兄):病理性白细胞增多,则常见于各种化脓性的球菌或杆菌的感染,如败血症、肺炎、脑膜炎、急性扁桃体炎、急性肾炎、急性胆囊炎及猩红热等;而白细胞的减少,则常见于病毒引起的流感、麻疹、肝炎或伤寒、布氏杆菌病等某些杆菌性疾病。也可见于粟粒性肺结核或败血症等严重感染及磺胺药、砷、苯及放射性物质中毒时。

CRP(二师兄):是急性时相反应蛋白,在感染发生后6-8小时开始升高,24-48小时达到顶峰。升高幅度与细菌感染的程度呈正相关。是鉴别细菌感染与病毒感染的指标,病毒感染时CRP一般不增高,但在自身免疫性疾病时也增高。

SAA(三师兄):是个灵敏的参数,它在炎症反应大约5-6h后开始升高,且上升时间早于CRP,病毒感染时上升显着,病原清除后,SAA又迅速将至正常水平,因此可做为反映病毒感染和炎症控制的敏感指标。

PCT(四师弟):是降钙素的前体物质,一般机体受到细菌感染时,血清PCT水平显着升高,是反映感染程度的重要生物学指标,在脓毒症的早期诊断及预后评估中具有重要价值。研究表明,动态监测血清PCT水平有助于反映脓毒症患者全身炎性反应的严重程度、炎症过程恢复期的筛检、指导治疗及疗效判断。

目前临床常见的检测组合方式如下

多项指标联合诊断临床意义

虽然在感染的诊断方面,WBC、CRP、SAA和PCT都是非特异性感染指标,但是通过这些非特异性感染指标的组合使用,我们也可以获得快速的、特异性的辅助诊断,在必要时再结合血培养结果,不仅能够帮助临床医生及时有效的判断感染类型,还能避免抗生素滥用,对临床合理使用药物具有重要意义。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1665845, encodeId=be1716658459e, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Fri Jan 31 20:39:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799434, encodeId=2bbd1e99434b4, content=<a href='/topic/show?id=eb5ae068750' target=_blank style='color:#2F92EE;'>#疾病检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70687, encryptionId=eb5ae068750, topicName=疾病检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Tue Sep 08 11:39:00 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375305, encodeId=c2ea3e530539, content=感染性疾病检测。, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 15 20:20:50 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374682, encodeId=4f503e468231, content=感染的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 01 20:22:30 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655471, encodeId=a21116554e1a4, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Tue Nov 19 05:39:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1665845, encodeId=be1716658459e, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Fri Jan 31 20:39:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799434, encodeId=2bbd1e99434b4, content=<a href='/topic/show?id=eb5ae068750' target=_blank style='color:#2F92EE;'>#疾病检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70687, encryptionId=eb5ae068750, topicName=疾病检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Tue Sep 08 11:39:00 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375305, encodeId=c2ea3e530539, content=感染性疾病检测。, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 15 20:20:50 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374682, encodeId=4f503e468231, content=感染的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 01 20:22:30 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655471, encodeId=a21116554e1a4, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Tue Nov 19 05:39:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1665845, encodeId=be1716658459e, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Fri Jan 31 20:39:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799434, encodeId=2bbd1e99434b4, content=<a href='/topic/show?id=eb5ae068750' target=_blank style='color:#2F92EE;'>#疾病检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70687, encryptionId=eb5ae068750, topicName=疾病检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Tue Sep 08 11:39:00 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375305, encodeId=c2ea3e530539, content=感染性疾病检测。, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 15 20:20:50 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374682, encodeId=4f503e468231, content=感染的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 01 20:22:30 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655471, encodeId=a21116554e1a4, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Tue Nov 19 05:39:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
    2019-11-15 jyzxjiangqin

    感染性疾病检测。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1665845, encodeId=be1716658459e, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Fri Jan 31 20:39:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799434, encodeId=2bbd1e99434b4, content=<a href='/topic/show?id=eb5ae068750' target=_blank style='color:#2F92EE;'>#疾病检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70687, encryptionId=eb5ae068750, topicName=疾病检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Tue Sep 08 11:39:00 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375305, encodeId=c2ea3e530539, content=感染性疾病检测。, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 15 20:20:50 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374682, encodeId=4f503e468231, content=感染的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 01 20:22:30 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655471, encodeId=a21116554e1a4, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Tue Nov 19 05:39:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]
    2019-11-01 jyzxjiangqin

    感染的治疗。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1665845, encodeId=be1716658459e, content=<a href='/topic/show?id=978d53318de' target=_blank style='color:#2F92EE;'>#感染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53318, encryptionId=978d53318de, topicName=感染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97fa26021282, createdName=12498fa0m19暂无昵称, createdTime=Fri Jan 31 20:39:00 CST 2020, time=2020-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799434, encodeId=2bbd1e99434b4, content=<a href='/topic/show?id=eb5ae068750' target=_blank style='color:#2F92EE;'>#疾病检测#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70687, encryptionId=eb5ae068750, topicName=疾病检测)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Tue Sep 08 11:39:00 CST 2020, time=2020-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375305, encodeId=c2ea3e530539, content=感染性疾病检测。, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 15 20:20:50 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=374682, encodeId=4f503e468231, content=感染的治疗。, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Nov 01 20:22:30 CST 2019, time=2019-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655471, encodeId=a21116554e1a4, content=<a href='/topic/show?id=7c2853311ac' target=_blank style='color:#2F92EE;'>#感染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53311, encryptionId=7c2853311ac, topicName=感染性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=583d24724321, createdName=charl1234575, createdTime=Tue Nov 19 05:39:00 CST 2019, time=2019-11-19, status=1, ipAttribution=)]

相关资讯

BMJ:压力相关疾病与后继严重感染风险

压力相关疾病与随后严重感染风险有关

双侧膝关节人工关节置换术后相继感染1例

患者,女性,62 岁,因“左膝关节置换术后疼痛半年,加重伴流脓1 月,右膝关节旷置术后疼痛伴活动受限2 月”入住宁夏医科大学总医院脊柱骨科。患者15 年前无诱因下出现双膝关节疼痛不适,2008 年患者自觉上述症状加重并出现双膝关节活动受限,至宁夏武警医院就诊,于2008 年6 月8 日行“左膝关节置换术”,2013 年12 月13 日于宁夏武警医院行“右侧人工膝关节置换术”。2016 年患者无明显

JAMA Neurol:利妥昔单抗、那他珠单抗、芬戈莫德治疗MS感染风险差异研究

研究发现,MS患者感染风险普遍增加,这一点因治疗而异,干扰素β和GA的感染风险最低;在较新的治疗方法中,利妥昔单抗的严重感染风险最高

病例分享|旅游后感染肝吸虫

年龄:53岁 性别:女 主诉:反复发热半月余 现病史:患者于2019年6月16日因发热在江苏省人民医院就诊,体温达39°C以上,高热期与无热期交替出现。

Diabetes Care:糖尿病增加多种感染发生风险

根据发表在Diabetes Care上的研究结果,与没有糖尿病的成人相比,患有糖尿病的成人发生流感、蜂窝织炎和败血症等感染的风险更高。美国疾病控制与预防中心糖尿病转化部门Jessica L. Harding博士及其同事在研究报告中写道,糖尿病患者数量增加可能会导致未来感染人数增多,这将对医疗负担和患者管理产生重要影响。卫生保健提供者需要认识到糖尿病是感染的一个重要危险因素,这可能有助于改善患者管理

Nat Commun:研究团队在肝脏中发现有助于预防侵袭性真菌感染的新机制

研究团队在肝脏中发现有助于预防侵袭性真菌感染的新机制。

Baidu
map
Baidu
map
Baidu
map